FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1432-1438 November 4, 1999 Number 19 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Herpes simplex virus (HSV) infections are endemic, but the clinical characteristics of newly acquired HSV type 1 (HSV-1) and HSV type 2 (HSV-2) infections in adults have not been rigorously defined.

Methods We monitored 2393 sexually active HSV-2–seronegative persons for clinical and serologic evidence of new HSV infection. Of the participants, 1508 were seropositive for HSV-1 and 885 were seronegative. Charts were reviewed in a blinded manner for classification of those with genitourinary or oropharyngeal symptoms. Charts were also reviewed for all 174 persons with HSV seroconversion.

Results The rates of new HSV-1 and HSV-2 infections were 1.6 and 5.1 cases per 100 person-years, respectively. Of the 155 new HSV-2 infections, 57 (37 percent) were symptomatic, 47 of which (82 percent) were correctly diagnosed at presentation. Among the 74 patients given a clinical diagnosis of genital HSV-2 infection during the study, 60 were given a correct diagnosis and 14 were given an incorrect diagnosis, for a ratio of true positive results to false positive results of 4:1. Among the 98 persons with asymptomatic HSV-2 seroconversion, 15 percent had genital lesions at some time during follow-up. Women were more likely than men to acquire HSV-2 (P<0.01) and to have symptomatic infection. Previous HSV-1 infection did not reduce the rate of HSV-2 infection, but it did increase the likelihood of asymptomatic seroconversion, as compared with symptomatic seroconversion, by a factor of 2.6 (P<0.001). Of the 19 new HSV-1 infections, 12 were symptomatic. The rates of symptomatic genital HSV-1 infection and oropharyngeal HSV-1 infection were the same (0.5 case per 100 person-years).

Conclusions Nearly 40 percent of newly acquired HSV-2 infections and nearly two thirds of new HSV-1 infections are symptomatic. Among sexually active adults, new genital HSV-1 infections are as common as new oropharyngeal HSV-1 infections.

Source Information

From Chiron, Emeryville, Calif. (A.G.M.L., W.P.L.); the University of Washington, Seattle (L.C., R.L.A); and the National Institutes of Health, Bethesda, Md. (S.E.S.).

Address reprint requests to Dr. Corey at 1100 Fairview Ave. N. (D3-100), Seattle, WA 98109.

Full Text of this Article

This article has been cited by other articles:

• Kwant-Mitchell, A., Ashkar, A. A., Rosenthal, K. L. (2009). Mucosal Innate and Adaptive Immune Responses against Herpes Simplex Virus Type 2 in a Humanized Mouse Model. J. Virol. 83: 10664-10676 [Abstract] [Full Text]  
• Chentoufi, A. A., Binder, N. R., Berka, N., Durand, G., Nguyen, A., Bettahi, I., Maillere, B., BenMohamed, L. (2008). Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B. J. Virol. 82: 11792-11802 [Abstract] [Full Text]  
• Kim, M., Taylor, J., Sidney, J., Mikloska, Z., Bodsworth, N., Lagios, K., Dunckley, H., Byth-Wilson, K., Denis, M., Finlayson, R., Khanna, R., Sette, A., Cunningham, A. L. (2008). Immunodominant Epitopes in Herpes Simplex Virus Type 2 Glycoprotein D Are Recognized by CD4 Lymphocytes from Both HSV-1 and HSV-2 Seropositive Subjects. J. Immunol. 181: 6604-6615 [Abstract] [Full Text]  
• Svensson, A., Bergin, A.-M. H., Lowhagen, G.-B., Tunback, P., Bellner, L., Padyukov, L., Eriksson, K. (2008). A 3'-untranslated region polymorphism in the TBX21 gene encoding T-bet is a risk factor for genital herpes simplex virus type 2 infection in humans. J. Gen. Virol. 89: 2262-2268 [Abstract] [Full Text]  
• Brittle, E. E., Wang, F., Lubinski, J. M., Bunte, R. M., Friedman, H. M. (2008). A Replication-Competent, Neuronal Spread-Defective, Live Attenuated Herpes Simplex Virus Type 1 Vaccine. J. Virol. 82: 8431-8441 [Abstract] [Full Text]  
• Chentoufi, A. A., Zhang, X., Lamberth, K., Dasgupta, G., Bettahi, I., Nguyen, A., Wu, M., Zhu, X., Mohebbi, A., Buus, S., Wechsler, S. L., Nesburn, A. B., BenMohamed, L. (2008). HLA-A*0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D. J. Immunol. 180: 426-437 [Abstract] [Full Text]  
• Bettahi, I., Nesburn, A. B., Yoon, S., Zhang, X., Mohebbi, A., Sue, V., Vanderberg, A., Wechsler, S. L., BenMohamed, L. (2007). Protective Immunity against Ocular Herpes Infection and Disease Induced by Highly Immunogenic Self-Adjuvanting Glycoprotein D Lipopeptide Vaccines. IOVS 48: 4643-4653 [Abstract] [Full Text]  
• Bitnun, A., Elbers, J. M., MacGregor, D., Tellier, R., Richardson, S. E. (2007). Mycoplasma pneumoniae Encephalitis and Reactivation of Herpes Simplex Virus: In Reply. Pediatrics 119: 1257-1258 [Full Text]  
• Geretti, A M (2006). Genital herpes. Sex. Transm. Infect. 82: iv31-iv34 [Full Text]  
• Xu, F., Sternberg, M. R., Kottiri, B. J., McQuillan, G. M., Lee, F. K., Nahmias, A. J., Berman, S. M., Markowitz, L. E. (2006). Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.. JAMA 296: 964-973 [Abstract] [Full Text]  
• Wald, A (2006). Genital HSV-1 infections.. Sex. Transm. Infect. 82: 189-190 [Full Text]  
• Haddow, L J, Dave, B, Mindel, A, McPhie, K A, Chung, C, Marks, C, Dwyer, D E (2006). Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003.. Sex. Transm. Infect. 82: 255-259 [Abstract] [Full Text]  
• Smith, J S, Rosinska, M, Trzcinska, A, Pimenta, J M, Litwinska, B, Siennicka, J (2006). Type specific seroprevalence of HSV-1 and HSV-2 in four geographical regions of Poland.. Sex. Transm. Infect. 82: 159-163 [Abstract] [Full Text]  
• Looker, K J, Garnett, G P (2005). A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex. Transm. Infect. 81: 103-107 [Abstract] [Full Text]  
• Hoshino, Y., Dalai, S. K., Wang, K., Pesnicak, L., Lau, T. Y., Knipe, D. M., Cohen, J. I., Straus, S. E. (2005). Comparative Efficacy and Immunogenicity of Replication-Defective, Recombinant Glycoprotein, and DNA Vaccines for Herpes Simplex Virus 2 Infections in Mice and Guinea Pigs. J. Virol. 79: 410-418 [Abstract] [Full Text]  
• Eriksson, K., Bellner, L., Gorander, S., Lowhagen, G.-B., Tunback, P., Rydberg, K., Liljeqvist, J.-A. (2004). CD4+ T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals. J. Gen. Virol. 85: 2139-2147 [Abstract] [Full Text]  
• Tran, T, Druce, J D, Catton, M C, Kelly, H, Birch, C J (2004). Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003. Sex. Transm. Infect. 80: 277-279 [Abstract] [Full Text]  
• Pebody, R G, Andrews, N, Brown, D, Gopal, R, de Melker, H, Francois, G, Gatcheva, N, Hellenbrand, W, Jokinen, S, Klavs, I, Kojouharova, M, Kortbeek, T, Kriz, B, Prosenc, K, Roubalova, K, Teocharov, P, Thierfelder, W, Valle, M, Van Damme, P, Vranckx, R (2004). The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex. Transm. Infect. 80: 185-191 [Abstract] [Full Text]  
• Patrick, D M, Rosenthal, S L, Stanberry, L R, Hurst, C, Ebel, C (2004). Patient satisfaction with care for genital herpes: insights from a global survey. Sex. Transm. Infect. 80: 192-197 [Abstract] [Full Text]  
• Waggoner-Fountain, L. A., Grossman, L. B. (2004). Herpes Simplex Virus. Pediatr. Rev. 25: 86-93 [Full Text]  
• Garnett, G P, Dubin, G, Slaoui, M, Darcis, T (2004). The potential epidemiological impact of a genital herpes vaccine for women. Sex. Transm. Infect. 80: 24-29 [Abstract] [Full Text]  
• Corey, L., Wald, A., Patel, R., Sacks, S. L., Tyring, S. K., Warren, T., Douglas, J. M. Jr., Paavonen, J., Morrow, R. A., Beutner, K. R., Stratchounsky, L. S., Mertz, G., Keene, O. N., Watson, H. A., Tait, D., Vargas-Cortes, M., the Valacyclovir HSV Transmission Study Group, (2004). Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes. NEJM 350: 11-20 [Abstract] [Full Text]  
• Tang, J W, Coward, L J, Davies, N W S, Geretti, A M, Howard, R S, Hirsch, N P, Ward, K N (2003). Brain stem encephalitis caused by primary herpes simplex 2 infection in a young woman. J. Neurol. Neurosurg. Psychiatry 74: 1323-1325 [Abstract] [Full Text]  
• BenMohamed, L., Bertrand, G., McNamara, C. D., Gras-Masse, H., Hammer, J., Wechsler, S. L., Nesburn, A. B. (2003). Identification of Novel Immunodominant CD4+ Th1-Type T-Cell Peptide Epitopes from Herpes Simplex Virus Glycoprotein D That Confer Protective Immunity. J. Virol. 77: 9463-9473 [Abstract] [Full Text]  
• Cowan, F M, French, R S, Mayaud, P, Gopal, R, Robinson, N J, de Oliveira, S A., Faillace, T, Uuskula, A, Nygard-Kibur, M, Ramalingam, S, Sridharan, G, El Aouad, R, Alami, K, Rbai, M, Sunil-Chandra, N P, Brown, D W (2003). Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex. Transm. Infect. 79: 286-290 [Abstract] [Full Text]  
• Fisman, D N, Hook, E W III, Goldie, S J (2003). Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2. Sex. Transm. Infect. 79: 45-52 [Abstract] [Full Text]  
• Koelle, D. M., Corey, L. (2003). Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research. Clin. Microbiol. Rev. 16: 96-113 [Abstract] [Full Text]  
• Howard, M., Sellors, J. W., Jang, D., Robinson, N. J., Fearon, M., Kaczorowski, J., Chernesky, M. (2003). Regional Distribution of Antibodies to Herpes Simplex Virus Type 1 (HSV-1) and HSV-2 in Men and Women in Ontario, Canada. J. Clin. Microbiol. 41: 84-89 [Abstract] [Full Text]  
• Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S., Tyring, S., Aoki, F. Y., Slaoui, M., Denis, M., Vandepapeliere, P., Dubin, G., the GlaxoSmithKline Herpes Vaccine Efficacy Study, (2002). Glycoprotein-D-Adjuvant Vaccine to Prevent Genital Herpes. NEJM 347: 1652-1661 [Abstract] [Full Text]  
• SIEGEL, M. A. (2002). Diagnosis and management of recurrent herpes simplex infections. Journal of the American Dental Association 133: 1245-1249 [Abstract] [Full Text]  
• Workowski, K. A., Levine, W. C., Wasserheit, J. N. (2002). U.S. Centers for Disease Control and Prevention Guidelines for the Treatment of Sexually Transmitted Diseases: An Opportunity To Unify Clinical and Public Health Practice. ANN INTERN MED 137: 255-262 [Abstract] [Full Text]  
• Lubinski, J. M., Jiang, M., Hook, L., Chang, Y., Sarver, C., Mastellos, D., Lambris, J. D., Cohen, G. H., Eisenberg, R. J., Friedman, H. M. (2002). Herpes Simplex Virus Type 1 Evades the Effects of Antibody and Complement In Vivo. J. Virol. 76: 9232-9241 [Abstract] [Full Text]  
• Wills, M R, Carmichael, A J, Sissons, J G P (2002). Vaccines against persistent DNA virus infections. Br Med Bull 62: 125-138 [Abstract] [Full Text]  
• Scoular, A (2002). Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sex. Transm. Infect. 78: 160-165 [Abstract] [Full Text]  
• Garnett, G P (2002). The geographical and temporal evolution of sexually transmitted disease epidemics. Sex. Transm. Infect. 78: i14-19 [Abstract] [Full Text]  
• Liljeqvist, J.-A., Trybala, E., Hoebeke, J., Svennerholm, B., Bergstrom, T. (2002). Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J. Gen. Virol. 83: 157-165 [Abstract] [Full Text]  
• Eberhart-Phillips, J. E, Dickson, N. P, Paul, C., Herbison, G P., Taylor, J., Cunningham, A. L (2001). Rising incidence and prevalence of herpes simplex type 2 infection in a cohort of 26 year old New Zealanders. Sex. Transm. Infect. 77: 353-357 [Abstract] [Full Text]  
• Brabin, L. (2001). Hormonal markers of susceptibility to sexually transmitted infections: are we taking them seriously?. BMJ 323: 394-395 [Full Text]  
• Ashley, R. L (2001). Sorting out the new HSV type specific antibody tests. Sex. Transm. Infect. 77: 232-237 [Abstract] [Full Text]  
• Roest, R., van der Meijden, W., van Dijk, G, Groen, J, Mulder, P., Verjans, G., Osterhaus, A. (2001). Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic. Int J Epidemiol 30: 580-588 [Abstract] [Full Text]  
• Gilson, R. J C, Mindel, A. (2001). Recent advances: Sexually transmitted infections. BMJ 322: 1160-1164 [Full Text]  
• Armstrong, G. L., Schillinger, J., Markowitz, L., Nahmias, A. J., Johnson, R. E., McQuillan, G. M., St. Louis, M. E. (2001). Incidence of Herpes Simplex Virus Type 2 Infection in the United States. Am J Epidemiol 153: 912-920 [Abstract] [Full Text]  
• Koelle, D. M., Chen, H. B., Gavin, M. A., Wald, A., Kwok, W. W., Corey, L. (2001). CD8 CTL from Genital Herpes Simplex Lesions: Recognition of Viral Tegument and Immediate Early Proteins and Lysis of Infected Cutaneous Cells. J. Immunol. 166: 4049-4058 [Abstract] [Full Text]  
• Harle, P., Noisakran, S., Carr, D. J. J. (2001). The Application of a Plasmid DNA Encoding IFN-{{alpha}}1 Postinfection Enhances Cumulative Survival of Herpes Simplex Virus Type 2 Vaginally Infected Mice. J. Immunol. 166: 1803-1812 [Abstract] [Full Text]  
• Dukers, N. H. T. M., Bruisten, S. M., van den Hoek, J. A. R., de Wit, J. B. F., van Doornum, G. J. J., Coutinho, R. A. (2000). Strong Decline in Herpes Simplex Virus Antibodies Over Time among Young Homosexual Men Is Associated with Changing Sexual Behavior. Am J Epidemiol 152: 666-673 [Abstract] [Full Text]  
• Drake, S., Taylor, S., Brown, D., Pillay, D. (2000). Regular review: Improving the care of patients with genital herpes. BMJ 321: 619-623 [Full Text]  
• Lowhagen, G-B, Tunback, P, Andersson, K, Bergstrom, T, Johannisson, G (2000). First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex. Transm. Infect. 76: 179-182 [Abstract] [Full Text]  
• (2000). More Light Shed on Primary Herpes Simplex Infections. JWatch Infect. Diseases 2000: 8-8 [Full Text]  
• (1999). Natural History of New Infections with HSV Types 1 and 2. Journal Watch Dermatology 1999: 2-2 [Full Text]  
• (1999). Patterns of Primary Genital Herpes. JWatch General 1999: 1-1 [Full Text]